SpineGuard, a San Francisco and Paris, France-based medical device company, has raised $6.2m in funding.
Investors included Crédit Agricole Private Equity, Innoven Partenaires, A Plus Finance, and Delta Partners.
The company intends to use the funds to further extend its PediGuard platform for enhanced spinal screw placement. PediGuard is a handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. Real-time feedback is provided via audio and visual signals.
SpineGuard already launched PediGuard Curv earlier this year and is preparing for the limited release of its Cannulated PediGuard, a “smart needle” to address minimally invasive spine surgery.
The company was founded in 2009 by CEO Pierre Jérôme and Stéphane Bette, former executives at Medtronic Sofamor-Danek and SpineVision.
FinSMEs
27/09/2011